- Home
- FLWS vs LRMR Comparison
FLWS vs LRMR Comparison
Compare FLWS & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLWS | LRMR |
|---|---|---|
| Founded | 1976 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.0M | 280.0M |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLWS | LRMR |
|---|---|---|
| Price | $3.44 | $5.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $7.50 | ★ $16.14 |
| AVG Volume (30 Days) | 563.8K | ★ 6.3M |
| Earning Date | 05-04-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $1,151,921,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.45 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.93 | $1.61 |
| 52 Week High | $8.44 | $6.42 |
Technical Indicators
Market Signals| Indicator | FLWS | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 68.30 |
| Support Level | $3.04 | $3.18 |
| Resistance Level | $5.04 | $5.37 |
| Average True Range (ATR) | 0.25 | 0.46 |
| MACD | -0.00 | 0.28 |
| Stochastic Oscillator | 21.77 | 69.10 |
Price Performance
Historical ComparisonAbout FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.